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Edited by Ned ManteiAbstract Human bystin is a cytoplasmic protein directly bind-
ing to trophinin, a cell adhesion molecule potentially involved in
human embryo implantation. The present study shows that bystin
is expressed in luminal and glandular epithelia in the mouse
uterus at peri-implantation stages. In fertilized embryos, bystin
was not seen until blastocyst stage. Bystin expression started
during hatching and increased in expanded blastocyst. However,
bystin apparently disappeared from the blastocyst during
implantation. After implantation bystin re-appeared in the epi-
blast. Targeted disruption of the mouse bystin gene, Bysl, re-
sulted in embryonic lethality shortly after implantation,
indicating that bystin is essential for survival of mouse embryos.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Bystin was originally identiﬁed in a human trophoblastic cell
as a protein that forms a complex with trophinin and tastin
[1]. Trophinin is an intrinsic membrane protein that medi-
ates cell adhesion by homophilic trophinin–trophinin binding
[1–6]. Tastin and bystin are cytoplasmic proteins required for
trophinin to function as an eﬃcient cell adhesion molecule.
In humans, trophinin, tastin and bystin are expressed in the
trophoblast and endometrial glandular epithelial cells at the
utero-placental interphase or implantation site [4]. These
proteins are found in the human placenta in early stages of
pregnancy, but they disappear from the placenta later than
10 weeks pregnancy [4].
Genes encoding trophinin and tastin are only found in mam-
mals [2,7]. By contrast, the bystin gene, Bysl, is conserved
across a wide range of eukaryotes including yeast, nematodes,
insects, snakes, and mammals [1,8–11]. The yeast Bysl ortho-
logue, ENP1 or essential nuclear protein 1, is essential for veg-
etative growth of yeast [11]. Studies of Enp1 show that it plays
a role in pre-ribosomal RNA splicing and ribosome biogenesis
[12]. In Drosophila the bys gene, which is localized upstream of
the ribosomal S6 kinase gene (hence termed ‘‘by S6’’), is impli-*Corresponding author.
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is expressed in a tissue-speciﬁc manner during gastrulation
[13]. In the larval wing disc, bysmRNA is expressed in the ven-
tral and dorsal regions of the wing pouch, regions that give rise
to epithelia and that adhere to one another after the wing disc
everts. These studies suggest that bystin is generally involved in
cell growth but also in cell adhesion, particularly in metazoans.
To determine the in vivo role of bystin in mouse embryo
implantation, we analyzed the expression pattern of bystin
protein in the mouse embryos and the uterus in the peri-
implantation period. We also inactivated the Bysl gene in the
mouse, and found that Bysl null embryos could implant
in the uterus but failed to survive beyond embryonic day 6
(E6).2. Materials and methods
2.1. Mouse bystin antibodies
Rabbit antibodies were raised against a synthetic peptide, MEKL-
TEKQTEVETVC, in which cysteine was added for conjugation to key-
hole limpet hemocyanin. Antibodies were puriﬁed by aﬃnity
chromatography on a protein A Sepharose column followed by a pep-
tide-conjugated agarose column. Antibodies bound to the peptide col-
umn were eluted with 3 M guanidine–HCl and dialyzed against cold
PBS.2.2. Transfection and immunocytochemistry
A mouse bystin IMAGE cDNA clone containing a 1.7 kb (clone ID
4925307) open reading frame encoding full-length, 50 kDa bystin in
pCMVSPORT6 was obtained from Invitrogen (Carlsbad, CA). COS
cells grown on glass cover slips were transfected with the vector using
LipofectAmine (Invitrogen). Transfected cells were ﬁxed in 100%
methanol and subjected to immunoperoxidase analysis using the aﬃn-
ity puriﬁed rabbit anti-bystin antibody described above. Peroxidase
substrate AEC single solution was used for the color reaction (Zymed,
South San Francisco, CA).2.3. Immunohistochemistry of mouse tissues and embryos
Frozen uteri were sectioned (12 mm) and mounted onto poly-L-
lysine-coated glass slides and ﬁxed with cold methanol for 15 min.
Pre-implantation embryos were recovered from uteri, placed on the
positively charged slide glass, and centrifuged for 1 min in a cytocentri-
fuge. The embryo attached to the slide glass was ﬁxed with cold meth-
anol for 10 min. Uterine regions containing implanted embryos were
identiﬁed by an enlarged uterine wall or decidual reaction, and frozen
in O.C.T compound (Tissue Tek, Torrance, CA). Each section was
placed on a positively charged glass slide, ﬁxed in cold methanol,
and stained with anti-bystin antibody described above. Stained tissue
sections were lightly counter-stained with hematoxylin.blished by Elsevier B.V. All rights reserved.
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Mouse uterine tissue was homogenized in PBS containing 1% NP-40
and a protease inhibitor mix (Roche Applied Science, Indianapolis,
IN) and centrifuged. Supernatant proteins were subjected to Western
blot analysis as described [14], except that the antibody was diluted
with Can-Get-Signal solution (Toyobo, Osaka, Japan) to enhance anti-
body–antigen binding. Alpha-tubulin, an internal standard, was de-
tected using a mouse monoclonal antibody (Sigma, St Louis, MO).2.5. Construction of targeting vector
Agenomic clone ofmouseByslwas isolated from amouse genomic P1
plasmid library (Genome Systems, St. Louis, MO) by polymerase
chain reaction (PCR) ampliﬁcation using the forward primer 5 0-
TGGAGCCTGGTTCAAAGGTAGA-3 0 and the reverse primer
5 0-ATGCAGTGGCTTTTAGACCGG-3 0. The plasmid DNA was di-
gested withHindIII. A 9.3 kb fragment, which hybridized with a mouse
bystin cDNA probe was subcloned at the HindIII site of pBluescript II
KS+ for targeting vector construction. For positive selection a 2.9-kb
EcoRV–XhoI fragment including Bysl exons 3–6 was replaced with a
PGK-neo cassette in which the neomycin resistance gene is driven by
the phosphoglycerate kinase promoter. The HSV-TK cassette including
theHerpes simplex thymidine kinase gene was ligated at the 3 0 end of the
targeting vector for negative selection. Mouse embryonic stem (ES) D3
cells derived from 129/SvJ mice [15] were transfected with the linearized
vector (20 mg) by electroporation at 400 V, 250 mF, in a GenePulser
(BioRad, Hercules, CA). Transfected cells were selected in medium con-
taining 150 mg/ml geneticin (GibcoBRL,Gaithersburg,MD) and 2 mM
ganciclovir as described [14]. Screening of 296 ES clones by Southern
blot identiﬁed 11 homologous recombinants. Two clones showing a
modal chromosome number of 40 were used to inject blastocysts, which
were transferred to foster mothers to generate chimeric mice. Chimeras
werematedwith 129/SvJmice and alsowithC57BL6mice to obtain lines
carrying amutatedBysl allele.Micewere housed in the animal care facil-
ity at the Burnham Institute according to NIH and institutional guide-
lines concerning care and use of laboratory animals.2.6. Southern blot of mouse genomic DNA
Genomic DNA prepared from ES clones or mouse tail biopsies was
digested with EcoRI and separated by electrophoresis on 0.7% agarose
gels. DNAs were transferred to a NYTRAN PLUS membrane (Schlei-
cher & Schuell, Keene, NH) and ﬁxed under ultraviolet light
(1200 mJ). A DNA fragment encoding the 5 0 region outside of the tar-
geting vector was labeled with [a-32P]dCTP and used as a probe. Filters
were prehybridized at 35 C for 5 h in 6· SSPE containing 50% form-
amide, 5· Denhardt’s solution, 0.1% SDS, and 0.2 mg/ml denatured
salmon sperm DNA, and then hybridized in the same solution contain-
ing the 32P-labeled probe at 35 C for 20 h. Filters were washed three
times at 35 C for 10 min in 6· SSPE containing 0.1% SDS and sub-
jected to autoradiography.
2.7. Genotyping of mice and mouse embryos
Genotyping was carried out by PCR using genomic DNA isolated
from tail biopsies as described [14] or from preimplantation embryo
as described below. Primers for the Neo gene were: forward 5 0-
TAAGCTATCAGAGATGAAGT-30 and reverse 5 0-GCTAATAC-
CAGCACCATCAC-3 0. Ampliﬁcations were carried out in a Thermal
Cycler (Perkin–Elmer, model 2400) by denaturation at 94 C for
10 min, followed by 35 cycles for tail or 55 cycles for embryo of dena-
turation at 94 C for 30 s, annealing at 58 C for 60 s, extension at
72 C for 45 s, and further extension at 72 C for 10 min.
Analysis of the Bysl gene in pre-implantation embryos was carried
out by nested PCR directed at the sequence within exon 5. Primers
for the ﬁrst PCR were: forward, 5 0-CTTCCCCGAGTGCGAGAT-
GACATT-30 and reverse, 5 0-TCCATTCGCACCCTCACGACCA-3 0.
Ampliﬁcations were carried out by denaturation at 94 C for 3 min,
followed by 35 cycles of denaturation at 94 C for 30 s, annealing at
55 C for 30 s, extension at 72 C for 30 s, and further extension at
72 C for 7 min. Nested PCR was carried out using the following prim-
ers: forward 5 0-AAGGTCATCCCTGCACTGTC-30 and reverse 5 0-
CAGCAATGTCATCTCGCACT-30. Ampliﬁcation was carried out
in the same conditions as the ﬁrst PCR, except that annealing was at
58 C. Reaction products were separated on agarose gels and stained
with ethidium bromide. DNA bands were visualized under UV light
and photographed.Genomic DNA from pre-implantation stage embryos was prepared
as follows. Timed pregnancies were determined deﬁning E0.5 as the
morning of plug. Embryos were ﬂushed from the pregnant female
uterus at E2.5, E3.5, and E4.5. Each embryo was placed in a tube con-
taining 20 ml PBS, mixed with 20 ml DexPat (Pan-Vera, Madison,
WI), boiled for 10 min, and centrifuged to remove DexPat. Each super-
natant was mixed with 4 ml of 3 M Na-acetate and 100 ml ethanol and
left at 20 C for 20 h to precipitate genomic DNA.
Genotypings of E5.5, E6.5, and E7.5 embryos were carried out using
genomic DNA isolated from frozen sections of implanted embryos.
The uterus showing positivity for the decidual reaction was frozen
and sections were cut. Sections were placed on a slide, brieﬂy stained
with hematoxylin, and embryonic cells were collected using 21 gauge
needles. Genomic DNA was prepared using DexPat as described
above.
2.8. Adhesion of mouse blastocysts to HB-EGF-expressing cells
Binding of mouse blastocysts to 32D cells, which express membrane
bound form HB-EGF, was tested as described [16]. Brieﬂy, Bysl het-
erozygotes were mated and blastocysts were ﬂushed from the uteri of
pregnant females on E4.5. Hatched and well-expanded blastocysts
were placed in a Petri dish containing HT medium, and 32D cells
(1 · 105 cells/ml) were added to the blastocysts. Each blastocyst was in-
spected for the binding of 32D cells under phase contrast microscope
and scored.3. Results
3.1. Expression of bystin in mouse uterus and pre-implantation
mouse embryos
Fig. 1A shows the peptide sequences of full-length human
and mouse bystins. A polyclonal antibody was raised against
a synthetic peptide of underlined sequence. COS cells were
transfected with a mammalian expression vector encoding
the full-length mouse bystin cDNA and reacted with aﬃnity
puriﬁed anti-bystin antibody. The antibody did not react or
very weakly reacted with mock-transfected COS cells
(Fig. 1B-a). Under normal culture conditions, presumably
when most COS cells are at G1 phase, bystin was detected in
the cytoplasm (Fig. 1B-b). When transfected COS cells were
arrested at G1 phase by serum starvation following stimula-
tion with serum to induce mitosis, immunostaining was seen
in nuclei and nucleoli (Fig. 1B-d). This observation suggests
that bystin enters the nucleus before mitosis and moves to
nucleoli. In the presence of the peptide used for immunogen,
immunocytochemistry of transfected COS cells with the same
antibody showed no staining (Fig. 1B-e). These results veriﬁed
the speciﬁcity of anti-bystin antibody in immunocytochemistry
used in this study.
Western blot analysis of 293 T cells detected a 50 kDa band,
which became undetectable after pre-incubation of the anti-
body with the peptide used for immunogen (Fig. 1C, lanes
1). Immunoblots from lysates of 293T cells transfected with
cDNA encoding FLAG-tagged human bystin showed a strong
band of slightly lower mobility than endogenous bystin, which
became undetectable after pre-incubation with the peptide
(Fig. 1C, lanes 2). These results indicate that the antibody de-
tects both human and mouse bystin proteins. Western blot
analysis of mouse uterus with the same antibody showed a
50 kDa band and additional bands (Fig. 1D). When the anti-
body was pre-incubated with the peptide used for immunogen,
the 50 and 25 kDa bands disappeared (data not shown), sug-
gesting that they represent bystin. The presence of 50 kDa by-
stin indicates that human bystin that we identiﬁed previously
was truncated and lacked part of the 5 0 region, as commented
Fig. 1. Characterization of anti-bystin antibody by immunocytochemistry and Western blot. (A) Peptide sequences of full-length human (upper) and
mouse (lower) bystin proteins. The underlined sequence was used for antibody production. (B) Immunohistochemistry of COS cells transfected with
vector alone (a,c) or a vector encoding mouse bystin (b,d,e). Cells were reacted with an anti-bystin antibody with (e) or without (a–d) the peptide
used as immunogen. (C) Western blot analysis of FLAG-tagged human bystin. Each lane represents an untransfected (lane 1) and a transfected (lane
2) 293 T cell lysate. The ﬁlter was reacted with an anti-bystin antibody with (left) or without (right) the epitope peptide. (D) Western blot analysis of
mouse uterus tissues. Lanes 1 and 2: non-pregnant. Lanes 3–5, pregnant day 3.5 (lane 3), day 4.5 (lane 4) and day 5.5 (lane 6).
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band shown by an asterisk in Fig. 1D represents a bystin var-
iant or a fragment produced by proteolysis. Nonetheless, the
result suggests that bystin is expressed in both non-pregnant
and pregnant mouse uteri.Immunohistochemistry of non-pregnant mouse uteri showed
signals in the luminal epithelium and glandular epithelium
(Fig. 2A-a). When the same antibody was incubated with the
peptide used for the immunogen, signals disappeared (data
not shown), strongly suggesting that staining represents bystin.
Fig. 2. Immunohistochemistry of mouse uteri and embryos before, during and after implantation. (A) Mouse uterus from non-pregnant (a) and 4.5
day pregnant (b) mice. (B) Pre-implantation stage mouse embryos. Morulae (a), blastocysts during hatching (b), a hatched and expanded blastocyst
(c), and a hatched and one day cultured blastocyst (d). (C) Day 4.5 pregnant mouse uterus with implanting blastocyst. Bystin was seen in the uterine
luminal epithelial cells (le) and glandular epithelial cells (ge), at low (a) and high (b–d) magniﬁcation. Note that in luminal epithelial cells, bystin
localizes to the apical side (b). In luminal epithelial cells adjacent to the blastocyst, bystin localizes to the apical side, whereas trophectoderm cells do
not show bystin signals (c). Glandular epithelia cells strongly express bystin, whereas no polarization of bystin staining is seen in these cells (d). (D)
Implanted embryo at the epiblast stage or at day 5.5. (E) Implanted embryo and uterus at day 6.5. ge, glandular epithelia; le, luminal epithelia; bl,
blastocyst; tr, trophectoderm; ep, epiblast.
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abluminal sides of the epithelia. By contrast, immunostaining
of pregnant uteri showed uniform cytoplasmic staining with
greater signals at the apical side of the luminal epithelia
(Fig. 2A-b). Glandular epithelia were uniformly stained with
the antibody. These observations suggest that the presence of
embryos aﬀects bystin localization in these epithelial cells.
Immunocytochemistry of fertilized mouse eggs from the sin-
gle to the 16-cell stage showed no antibody signals (data not
shown). Weak signals were detected in morula stages
(Fig. 2B-a). Bystin immunostaining increased in the blastocyst
during hatching (Fig. 2B-b). Hatched and expanded blasto-
cysts were strongly positive for bystin (Fig. 2B-c). When a
hatched blastocyst was cultured in vitro for one day, bystin
staining was reduced (Fig. 2B-d). In extended cultures on ﬁbro-nectin-coated plate, bystin was not found in blastocyst-derived
cells (data not shown). These results show that bystin is ex-
pressed in pre-implantation stage mouse embryos, but that by-
stin disappears from the blastocyst after culturing in vitro.
During blastocyst implantation, uterine epithelial cells sur-
rounding the blastocyst showed strong bystin signals
(Fig. 2C-abc). Glandular epithelial cells also express bystin,
whereas bystin was uniformly localized in the cytoplasm
(Fig. 2C-d). In implanting embryos, bystin was not detected
in trophectoderm cells. Trophoblastic giant cells and ectopla-
cental cone were also negative for bystin (Fig. 2C-c). In lumi-
nal epithelial cells adjacent to the blastocyst, bystin was
localized to the apical side of the epithelium (Fig. 2C-c).
Shortly after implantation in E5.5 embryos, bystin appeared
in the epiblast (Fig. 2D), in contrast to the loss of bystin seen in
Table 1
Genotyping of oﬀspring resulted from the cross between Bysl+/
females and Bysl+/ males
Developmental stages Genotypes
+/+ +/ /
E2.5 8 15 5
E3.5 11 23 13
E4.5, morulae 13 20 9
E4.5, blastocyst 8 16 9
E5.5 6 11 3 4 e.d.a
E6.5 2 8 2b 4 e.d.
E7.5 7 15 1b 5 e.d.
E8.5 1 4 3b 1 e.d.
E10.5 10 25 0
Postnatal, 3 weeks 48 76 0
aEmpty deciduas. Genotype of embryos not available.
bEmbryos were degenerated.
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seen in E6.5 embryos (Fig. 2E-ab). Also on E6.5, bystin disap-
peared from the luminal epithelia surrounding the embryo,
whereas luminal epithelia or glandular epithelia distant from
the implantation site continued to express bystin. Immunohis-
tochemistries of mouse embryos older than E15 and adult mice
showed negative or weak signals in a variety of organs (data
not shown), suggesting that bystin is expressed widely and
weakly in a variety of cell types in the mouse embryos and
adult mice.
3.2. Targeted disruption of Bysl gene in the mouse
To determine the in vivo role of bystin in the mouse, Bysl
was disrupted by homologous recombination (Fig. 3A). Since
bystin contains many potential phosphorylation sites for pro-
tein kinases, we replaced these potentially modiﬁed regions,
which were encoded primarily by exons 3–6, with the Neo
gene. Following transfection of ES cells derived from the
129/SvJ strain [16] with the target vector, no morphological
or proliferative abnormalities were observed in homologously
recombined Bysl (+/) ES clones (Fig. 3B) under normal cul-
ture conditions.
Two Bysl (+/) ES clones were used for the blastocyst injec-
tion. Chimeric males were back-crossed with SvJ129 female
mice and with C57BL/6 mice. Genotyping of more than 2000
3 week-old pups (Fig. 3C) from two Bysl gene knockout lines
showed no Bysl null oﬀspring under either genetic background.Fig. 3. Production of Bysl gene knockout mouse. (A) Genomic DNA map
homologous recombinant ES clones. Genomic DNA digested by EcoRI was
Neo gene and Bysl gene of genomic tail DNA from pups produced from the c
and Bysl gene of mouse embryos produced from Bysl(+/) parents.Genotyping of pre-implantation stage embryos (Fig. 3D)
recovered from uteri revealed the presence of Bysl(/) em-
bryos (Table 1). In these embryos, no abnormal morphologies
were seen. Furthermore, all blastocysts showed positive bind-
ing by 32D cells expressing a membrane bound form of HB-
EGF [16], indicating that deletion of a large part of the Bysl
gene did not aﬀect adhesion of a blastocyst through the
EGF receptor, suggesting that loss of bystin does not aﬀect
binding between the EGF receptor and HB-EGF. Genotypingof the Bysl gene, and the Bysl targeting vector. (B) Southern blot of
probed by the 5 0 DNA probe shown in A. (C) Genotyping by PCR for
ross between Bysl (+/) parents. (D) Genotyping by PCR for Neo gene
Fig. 4. Histology of implanted E6.5 mouse embryos resulted from
Bysl(+/) parents. A pair of litter mates with each genotype Bysl(+/)
(upper) and Bysl(/) (lower) embryos is shown. Note that Bysl (/)
embryo was degenerated. Tissue sections were stained with hematox-
ylin.
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number of Bysl(/) embryos, suggesting that lethality oc-
curred after E3.5 and before E8.5 (Table 1).
Bysl(+/) females mated with Bysl(+/) males showed no
macroscopic signs of dead embryos in the uterus, suggesting
embryonic lethality occurred before embryonic growth taking
place or shortly after implantation. Morphological examina-
tion of frozen sections of mouse uterus showed degenerated
embryos at E6.5, and their genotypes were identiﬁed as
Bysl(/) (Fig. 4). These observations strongly suggest
that Bysl(/) embryos die after implantation, at around
E5.5–6.5.4. Discussion
The present study demonstrates that Bysl is essential for
mouse embryo survival. Bysl null embryos survive and develop
during pre-implantation stages (Table 1). Global gene expres-
sion analysis of delayed implantation model identiﬁed genes
diﬀerentially expressed between dormant and activated blasto-
cysts, and Bysl was one of the genes activated by estrogen [17].
However, successful implantation of bystin null embryos and
absence of bystin protein in the trophectoderm of an implant-
ing blastocyst (Fig. 2C-c) suggest that bystin does not play an
essential role in the initial attachment of a blastocyst to the
uterine epithelia in the mouse. Given that trophinin null mouse
embryos also implant [14], the present study indicates that nei-
ther trophinin nor bystin plays a signiﬁcant role in this process
in the mouse. The present study, however, clearly shows that
bystin is essential for mouse embryo survival after implanta-
tion. Similar embryonic lethality but with incomplete pene-
trance was detected in trophinin null embryos [14],
suggesting that trophinin and bystin may function together
after implantation. However, considering the maternally
deposited transcripts in early stage embryos, gene knockout
experiments may not have revealed the function of these pro-
teins in the embryos earlier than E6.
Bystin’s role in mammalian cell growth was previously sug-
gested by a study of brain injury in rat [18], which showed thatbystin is overexpressed in reactive astrocytes after injury. The
embryonic lethality of Bysl null embryos and bystin expression
in the epiblast shown in this study (Fig. 2D) strengthen the
hypothesis that bystin is essential for cell growth in mammals,
as epiblast or embryonic stem cells should proliferate rapidly
after implantation.
Bystin expression in the epiblast (Fig. 2D) is consistent with
a report showing that Bysl is one of 216 genes commonly ex-
pressed in embryonic, neural and hematopoietic stem cells.
Thus Bysl is a speciﬁc stem cell marker. Bysl is also included
in a gene cluster of stem cell markers on mouse chromosome
16 [19]. The present study therefore supports the idea that Bysl
may play an important role in embryonic stem cells.
Studies of ribosomal biogenesis in yeast have shown that the
bystin orthologue Enp1 is required for synthesis of 40S ribo-
somal subunits by functioning in their nuclear export
[12,20,21]. Formation of eukaryotic ribosomes occurs predom-
inantly in the nucleoli, but late maturation steps take place in
both the nucleoplasm and cytoplasm [22]. The presence of by-
stin in the cytoplasm during G1 phase (Fig. 1B-b) and in the
nucleus in G2 phase (Fig. 1B-d) suggests a role of bystin in cel-
lular processes following mitosis, such as ribosomal biogenesis
in nucleoli, as has been reported for ENP1, the bystin yeast
orthologue [11,12,19,20]. The observation of bystin in the
nucleoli (Fig. 1B-d) supports this hypothesis.
Although information relevant to the function of human
BYSL is limited except for its potential involvement in human
embryo implantation, the publicly available database indicates
that its expression is elevated in many human cancers. In par-
ticular, bystin is overexpressed in prostate cancer cells at peri-
neural invasion [23]. Microarray analysis also identiﬁed tastin,
another trophinin-associated protein, as a prominently overex-
pressed gene in prostate cancer [24]. Perineural invasion likely
provides a microenvironment conferring a survival advantage
for prostate cancer cells. Furthermore, network reverse engi-
neering, which enables indentiﬁcation of co-regulated genes
from genome-wide expression proﬁles identiﬁed BYSL as the
most co-regulated gene to the Myc proto-oncogene in humans
[25]. Since overexpression of c-Myc in the mouse prostate
caused prostate cancer [26], bystin’s function in cell prolifera-
tion may be closely connected with c-Myc.
In higher organisms, many cellular functions are controlled
by cell–cell interactions. It is possible that bystin participates
in cytoplasmic signaling in a manner sensitive to cell adhesion.
It is tempting to speculate that some human cancers may be
promoted by a mechanism similar to trophoblast invasion
and proliferation in embryo implantation. Further studies on
bystin as well as trophinin and tastin will provide a better
understanding of these processes and may suggest therapeutic
strategies against human cancers.
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